Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Psychiatry & Neuroscience

• Publication date

  2011-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1503/jpn.100048PMID 21223646PMCID PMC3080515
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Brain-derived neurotrophic factor: role in depression and suicide

  2009cited by this paper
• Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains.

  2009cited by this paper
• Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia.

  2008cited by this paper
• Circuitry-based gene expression profiles in GABA cells of the trisynaptic pathway in schizophrenics versus bipolars

  2008cited by this paper
• Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy.

  2008cited by this paper
• What Does the Anatomical Organization of the Entorhinal Cortex Tell Us?

  2008cited by this paper
• New insights into BDNF function in depression and anxiety

  2007cited by this paper
• Patterns of gene expression in the limbic system of suicides with and without major depression

  2007cited by this paper
• Parvalbumin neurons in the entorhinal cortex of subjects diagnosed with bipolar disorder or schizophrenia.

  2007cited by this paper
• Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars

  2007cited by this paper
• A neurotrophic model for stress-related mood disorders.

  2006cited by this paper
• BDNF Val66Met polymorphism and GAD67 mRNA expression in the prefrontal cortex of subjects with schizophrenia.

  2006cited by this paper
• Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains.

  2005cited by this paper
• Relationship of Brain-Derived Neurotrophic Factor and Its Receptor TrkB to Altered Inhibitory Prefrontal Circuitry in Schizophrenia

  2005cited by this paper
• Hippocampal and ventricular volumes in psychotic and nonpsychotic bipolar patients compared with schizophrenia patients and community control subjects: a pilot study.

  2005cited by this paper
• Regional cerebral blood flow in patients with schizophrenia

  2005cited by this paper
• Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia

  2005cited by this paper
• Septal cholinergic afferents regulate expression of brain-derived neurotrophic factor andβ-nerve growth factor mRNA in rat hippocampus

  2005cited by this paper
• Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts.

  2005cited by this paper
• Hippocampal volume and depression: a meta-analysis of MRI studies.

  2004cited by this paper
• Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium

  2004cited by this paper
• The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications

  2004cited by this paper
• Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia

  2003cited by this paper
• Immunohistochemical study of brain-derived neurotrophic factor and its receptor, TrkB, in the hippocampal formation of schizophrenic brains.

  2003cited by this paper
• Impaired hippocampal recruitment during normal modulation of memory performance in schizophrenia.

  2003cited by this paper
• The neuropathology of primary mood disorder.

  2002cited by this paper
• Brain-Derived Neurotrophic Factor Promotes the Maturation of GABAergic Mechanisms in Cultured Hippocampal Neurons

  2002cited by this paper
• Cell pathology in bipolar disorder.

  2002cited by this paper
• An fMRI study of facial emotion processing in patients with schizophrenia.

  2002cited by this paper
• A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia.

  2002cited by this paper
• Hippocampal neurons in schizophrenia

  2002cited by this paper
• Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia.

  2002cited by this paper
• Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses.

  2001cited by this paper
• Hippocampal morphometry in depressed patients and control subjects: relations to anxiety symptoms.

  2001cited by this paper
• Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication.

  2001cited by this paper
• GABAergic Interneurons: Implications for Understanding Schizophrenia and Bipolar Disorder

  2001cited by this paper
• Brain-Derived Neurotrophic Factor Differentially Regulates Excitatory and Inhibitory Synaptic Transmission in Hippocampal Cultures

  2000cited by this paper
• Neuronal Activity and Brain-Derived Neurotrophic Factor Regulate the Density of Inhibitory Synapses in Organotypic Slice Cultures of Postnatal Hippocampus

  2000cited by this paper
• The stanley foundation brain collection and neuropathology consortium.

  2000cited by this paper
• Cell biology of the hippocampal formation in schizophrenia.

  1999cited by this paper
• Functional imaging of memory retrieval in deficit vs nondeficit schizophrenia.

  1999cited by this paper
• A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives.

  1998cited by this paper
• Impaired recruitment of the hippocampus during conscious recollection in schizophrenia

  1998cited by this paper
• A Qualitative and Quantitative Analysis of the Entorhinal Cortex in Schizophrenia

  1997cited by this paper
• A qualitative and quantitative analysis of the entorhinal cortex in schizophrenia.

  1997cited by this paper
• TrkB Signaling Is Required for Postnatal Survival of CNS Neurons and Protects Hippocampal and Motor Neurons from Axotomy-Induced Cell Death

  1997cited by this paper
• Cytoarchitecture of the entorhinal cortex in schizophrenia.

  1997cited by this paper
• The entorhinal cortex: an examination of cyto- and myeloarchitectonic organization in humans.

  1997cited by this paper
• Regional cerebral blood flow in patients with schizophrenia: relevance to symptom structures.

  1996cited by this paper
• Neuronal coexistence of trkB and glutamic acid decarboxylase67 mRNAs in rat hippocampus.

  1996cited by this paper
• The human entorhinal cortex: A cytoarchitectonic analysis

  1995cited by this paper
• A functional neuroanatomy of hallucinations in schizophrenia

  1995cited by this paper
• Resting cerebral glucose metabolism in first-episode and previously treated patients with schizophrenia relates to clinical features.

  1995cited by this paper
• Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development.

  1994cited by this paper
• Entorhinal cortex regulation of multiple brain-derived neurotrophic factor promoters in the rat hippocampus.

  1993cited by this paper
• Cortical transynaptic activation of tyrosine kinase receptor trkB messenger RNA expression in rat hippocampus.

  1992cited by this paper
• Patterns of Cerebral Blood Flow in Schizophrenia

  1992cited by this paper
• The left medial temporal region and schizophrenia. A PET study.

  1992cited by this paper
• Interplay between glutamate and gamma-aminobutyric acid transmitter systems in the physiological regulation of brain-derived neurotrophic factor and nerve growth factor synthesis in hippocampal neurons.

  1991cited by this paper
• Optimization of cRNA probein situ hybridization methodology for localization of glucocorticoid receptor mRNA in rat brain: A detailed protocol

  1990cited by this paper
• Further aspects of cortical function, including hippocampus

  1987cited by this paper
• The Hippocampal Formation of the Primate Brain

  1987cited by this paper

• Gender-specific perspectives in schizophrenia: Recent advances and future directions.

  2026cites this paper
• Kinetic modelling and evaluation of the TrkA/B/C radioligand [18F]TRACK in the pig brain.

  2026cites this paper
• Neuroglia in mood disorders.

  2025cites this paper
• Zinc in psychosis (Review)

  2025cites this paper
• Coadministration of scopolamine and mGlu2 NAM VU6001966 as a novel antidepressant approach: Lowering effective dose and reducing cognitive side effects.

  2025cites this paper
• Transcriptional evidence of reduced BDNF trophic capacity in the post-mortem human midbrain of schizophrenia cases with high inflammation

  2025cites this paper
• Impact of physical exercise on the regulation of brain-derived neurotrophic factor in people with neurodegenerative diseases

  2025cites this paper
• The Intricate Relationship of Trk Receptors in Brain Diseases and Disorders

  2025cites this paper
• IL-4Rα signalling influences behavioural and immune responses in Trypanosoma brucei-infected mice: Evidence for iloprost as a neuroprotective agent

  2025cites this paper
• Epigenetic control of stress and environmental enrichment interplay on anxiety and prefrontal cortex BDNF expression.

  2025cites this paper
• Ferroptosis as a potential molecular mechanism of bipolar disorder

  2025cites this paper
• Genetic variants in GRIN2B and NTRK2 on the etiology and treatment response to valproate and lithium in patients with bipolar disorder

  2025cites this paper
• Brain-derived neurotrophic factor in the ventrolateral orbital cortex regulates spared nerve injury-induced neuropathic pain and related emotional disorders in mice.

  2025cites this paper
• Lifelong Impact of Prenatal Stress: Exacerbated Memory Impairments and Gene Expression Changes Under Adult Chronic Stress

  2025cites this paper
• BDNF Signaling and Pain Modulation

  2025cites this paper
• Targeting HINT1 to improve synaptic plasticity: toward loganin as a new antidepressant strategy

  2025cites this paper
• Janus kinase/signal transducer and activator of transcription pathway in schizophrenia (Review)

  2025cites this paper
• Psychosis of Epilepsy: An Update on Clinical Classification and Mechanism

  2025cites this paper
• Obesity and Depression: Common Link and Possible Targets.

  2024cites this paper
• Sex difference alters the behavioral and cognitive performance in a rat model of schizophrenia induced by sub-chronic ketamine.

  2024cites this paper
• Selenium Intake and Postnatal Depression—A Short Review

  2024cites this paper
• Association of gut dysbiosis with first‑episode psychosis (Review)

  2024cites this paper
• Low-carbohydrate diet as a disease modifier for relapse prevention of treatment-resistant depression. Spotlight on neuroplasticity and brain-derived neurotrophic factor

  2024cites this paper
• Morphogenetic theory of mental and cognitive disorders: the role of neurotrophic and guidance molecules

  2024cites this paper
• Brain-derived neurotrophic factor levels across psychiatric disorders: A systemic review and network meta-analysis.

  2024cites this paper
• New Insights into Contradictory Changes in Brain-Derived Neurotrophic Factor (BDNF) in Rodent Models of Posttraumatic Stress Disorder (PTSD)

  2024cites this paper
• Executive function and decision-making in Colombian patients with paranoid schizophrenia

  2024cites this paper
• Serum brain derived neurotrophic factor levels and post-stroke depression in ischemic stroke patients.

  2024cites this paper
• Role of soluble epoxide hydrolase in pain and depression comorbidity.

  2024cites this paper
• (2R,6R)-hydroxynorketamine alleviates PTSD-like endophenotypes by regulating the PI3K/AKT signaling pathway in rats.

  2024cites this paper
• Upregulation Effect of Citrus Species on Brain-Derived Neurotrophic Factor.

  2024cites this paper
• The potential role of the p75 receptor in schizophrenia: neuroimmunomodulation and making life or death decisions

  2024cites this paper
• Low-carbohydrate diet as a nutritional intervention in a major depression disorder: focus on relapse prevention

  2024cites this paper
• Reduced serum neurotrophic factors and monoamine neurotransmitters in epilepsy patients with comorbid depression

  2024cites this paper
• Links between trauma and psychosis (Review)

  2023cites this paper
• The Impact of Maternal Immune Activation on GABAergic Interneuron Development: A Systematic Review of Rodent Studies and their Translational Implications.

  2023cites this paper
• Exploration of interaction interface of TRKβ/BDNF through fingerprint analysis to disinter potential agonists

  2023cites this paper
• Molecular mechanisms of rapid-acting antidepressants: new perspectives for developing antidepressants.

  2023cites this paper
• Impact of Stress on Brain Morphology: Insights into Structural Biomarkers of Stress-related Disorders

  2023cites this paper
• Brain-wide changes in excitation-inhibition balance of major depressive disorder: a systematic review of topographic patterns of GABA- and glutamatergic alterations

  2023cites this paper
• Brain-derived neurotrophic factor (BDNF) in schizophrenia research: a quantitative review and future directions

  2023cites this paper
• Stability of dentate gyrus granule cell mossy fiber BDNF protein expression with age and resistance of granule cells to Alzheimer’s disease neuropathology in a mouse model

  2023cites this paper
• Chronic haloperidol administration downregulates select BDNF transcript and protein levels in the dorsolateral prefrontal cortex of rhesus monkeys

  2023cites this paper
• Effects of Tail Pinch on BDNF and trkB Expression in the Hippocampus of Roman Low- (RLA) and High-Avoidance (RHA) Rats

  2023cites this paper
• A consideration of the increased risk of schizophrenia due to prenatal maternal stress, and the possible role of microglia.

  2023cites this paper
• The Role of BDNF as a Biomarker in Cognitive and Sensory Neurodegeneration

  2023cites this paper
• Hippocampal subfield alterations in schizophrenia and major depressive disorder: a systematic review and network meta-analysis of anatomic MRI studies

  2023cites this paper
• LPS-induced inflammation reduces GABAergic interneuron markers and brain-derived neurotrophic factor in mouse prefrontal cortex and hippocampus

  2023cites this paper
• Enhanced methamphetamine sensitisation in a rat model of the brain-derived neurotrophic factor Val66Met variant: Sex differences and dopamine receptor gene expression.

  2023cites this paper
• Dentate Gyrus Granule Cells Show Stability of BDNF Protein Expression in Mossy Fiber Axons with Age, and Resistance to Alzheimer’s Disease Neuropathology in a Mouse Model

  2023cites this paper
• Caspase-1 affects chronic restraint stress-induced depression-like behaviors by modifying GABAergic dysfunction in the hippocampus

  2023cites this paper
• Interaction of Brain-Derived Neurotrophic Factor with the Effects of Chronic Methamphetamine on Prepulse Inhibition in Mice Is Independent of Dopamine D3 Receptors

  2023cites this paper
• The Zebrafish for Preclinical Psilocybin Research.

  2023cites this paper
• Association between NTRK2 Polymorphisms, Hippocampal Volumes and Treatment Resistance in Major Depressive Disorder

  2023cites this paper
• Mitochondrial Antioxidant SkQ1 Affects the GABAergic but Not the Glutamatergic System in the Hippocampus of Wistar and Senescence Accelerated OXYS Rats

  2023cites this paper
• Shugan Jieyu Capsule in Post-Stroke Depression Treatment: From Molecules to Systems

  2022cites this paper
• More than Addiction—The Nucleus Accumbens Contribution to Development of Mental Disorders and Neurodegenerative Diseases

  2022cites this paper
• Clostridium butyricum RH2 Alleviates Chronic Foot Shock Stress-Induced Behavioral Deficits in Rats via PAI-1

  2022cites this paper
• Female Carriers of the Met Allele of the BDNF Val66Met Polymorphism Develop Weaker Fear Memories in a Fear-Potentiated Startle Paradigm

  2022cites this paper
• Red Raspberry Extract Decreases Depression-Like Behavior in Rats by Modulating Neuroinflammation and Oxidative Stress

  2022cites this paper
• Acute Stress Induces Different Changes on the Expression of BDNF and trkB in the Mesocorticolimbic System of Two Lines of Rats Differing in Their Response to Stressors

  2022cites this paper
• Transcranial Ultrasound Stimulation Reverses Behavior Changes and the Expression of Calcium-Binding Protein in a Rodent Model of Schizophrenia

  2022cites this paper
• The effects of preventative cannabidiol in a male neuregulin 1 mouse model of schizophrenia

  2022cites this paper
• Delayed effects of neonatal immune activation on brain neurochemistry and hypothalamic–pituitary–adrenal axis functioning

  2022cites this paper
• New Frontiers in Neurodegeneration and Regeneration Associated with Brain-Derived Neurotrophic Factor and the rs6265 Single Nucleotide Polymorphism

  2022cites this paper
• Early Life Stress Affects Bdnf Regulation: A Role for Exercise Interventions

  2022cites this paper
• The Regulatory Effects of Taurine on Neurogenesis and Apoptosis of Neural Stem Cells in the Hippocampus of Rats.

  2022cites this paper
• BDNF receptor TrkB as the mediator of the antidepressant drug action

  2022cites this paper
• Corticosterone antagonist or TrkB agonist attenuates schizophrenia-like behavior in a mouse model combining Bdnf-e6 deficiency and developmental stress

  2022cites this paper
• Development of a method for the identification of rs6265 polymorphism in the human brain neurotrophic factor gene

  2021cites this paper
• Functional characterization and potential therapeutic avenues for variants in the NTRK2 gene causing developmental and epileptic encephalopathies

  2021cites this paper
• Cannabinoid Receptor Type 1 Regulates Drug Reward Behavior via Glutamate Decarboxylase 67 Transcription

  2021cites this paper
• Sustained NMDA receptor hypofunction impairs brain-derived neurotropic factor (BDNF) signalling in the prefrontal cortex (PFC), but not in the hippocampus, and disturbs PFC-dependent cognition in mice Running head: BDNF function is lost in PFC of PCP-treated mice

  2021cites this paper
• Stress Diminishes BDNF-stimulated TrkB Signaling, TrkB-NMDA Receptor Linkage and Neuronal Activity in the Rat Brain.

  2021cites this paper
• BRUCE silencing leads to axonal dystrophy by repressing autophagosome-lysosome fusion in Alzheimer’s disease

  2021cites this paper
• Dose-dependent opposite effects of nortriptyline on affective-like behavior in adolescent rats: Comparison with adult rats.

  2021cites this paper
• Childhood adversity and psychotic disorders: Epidemiological evidence, theoretical models and clinical considerations.

  2021cites this paper
• Sustained NMDA receptor hypofunction impairs brain-derived neurotropic factor signalling in the PFC, but not in the hippocampus, and disturbs PFC-dependent cognition in mice

  2021cites this paper
• Cinnamomum zeylanicum extract has antidepressant-like effects by increasing brain-derived neurotrophic factor (BDNF) and its receptor in prefrontal cortex of rats

  2021cites this paper
• Implications of Adult Neural Stem Cell Abnormalities in the Pathophysiological Mechanism of Schizophrenia

  2021cites this paper
• Cognitive Dysfunction in a Mouse Model of Cerebral Ischemia Influences Salivary Metabolomics

  2021cites this paper
• Brain-Derived Neurotrophic Factor Signaling in Depression and Antidepressant Action.

  2021cites this paper
• BDNF haploinsufficiency induces behavioral endophenotypes of schizophrenia in male mice that are rescued by enriched environment

  2021cites this paper
• Blood Brain-Derived Neurotrophic Factor (BDNF) and Major Depression: Do We Have a Translational Perspective?

  2021cites this paper
• An alternative splicing hypothesis for neuropathology of schizophrenia: evidence from studies on historical candidate genes and multi-omics data

  2021cites this paper
• A Meta-Analysis of Brain-Derived Neurotrophic Factor Effects on Brain Volume in Schizophrenia: Genotype and Serum Levels

  2021cites this paper
• Putting Cells in Motion: Advantages of Endogenous Boosting of BDNF Production

  2021cites this paper
• Reduced adult neurogenesis is associated with increased macrophages in the subependymal zone in schizophrenia

  2021cites this paper
• Kefir peptides exhibit antidepressant-like activity in mice through the BDNF/TrkB pathway.

  2021cites this paper
• The Epigenetic Overlap between Obesity and Mood Disorders: A Systematic Review

  2020cites this paper
• Crossing the Blood-Brain-Barrier: A bifunctional liposome for BDNF gene delivery – A Pilot Study

  2020cites this paper
• BDNF Overexpression in the Ventral Hippocampus Promotes Antidepressant- and Anxiolytic-Like Activity in Serotonin Transporter Knockout Rats

  2020cites this paper
• Cerebrospinal fluid neuroplasticity-associated protein levels in patients with psychiatric disorders: a multiplex immunoassay study

  2020cites this paper
• An Analysis of Five TrkB Gene Polymorphisms in Schizophrenia and the Interaction of Its Haplotype with rs6265 BDNF Gene Polymorphism

  2020cites this paper
• Modulation of DNA Methylation and Gene Expression in Rodent Cortical Neuroplasticity Pathways Exerts Rapid Antidepressant-Like Effects

  2020cites this paper
• Molecular alterations in the medial temporal lobe in schizophrenia.

  2020cites this paper
• Reduction in BDNF from Inefficient Precursor Conversion Influences Nest Building and Promotes Depressive-Like Behavior in Mice

  2020cites this paper
• Antidepressant Drugs and Physical Activity: A Possible Synergism in the Treatment of Major Depression?

  2020cites this paper
• Glutamate dehydrogenase deficiency disrupts glutamate homeostasis in hippocampus and prefrontal cortex and impairs recognition memory

  2020cites this paper
• Entorhinal cortex-based metabolic profiling of chronic restraint stress mice model of depression

  2020cites this paper